Literature DB >> 11483137

Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.

E G Bing1, M A Burnam, D Longshore, J A Fleishman, C D Sherbourne, A S London, B J Turner, F Eggan, R Beckman, B Vitiello, S C Morton, M Orlando, S A Bozzette, L Ortiz-Barron, M Shapiro.   

Abstract

BACKGROUND: There have been no previous nationally representative estimates of the prevalence of mental disorders and drug use among adults receiving care for human immunodeficiency virus (HIV) disease in the United States. It is also not known which clinical and sociodemographic factors are associated with these disorders. SUBJECTS AND METHODS: We enrolled a nationally representative probability sample of 2864 adults receiving care for HIV in the United States in 1996. Participants were administered a brief structured psychiatric instrument that screened for psychiatric disorders (major depression, dysthymia, generalized anxiety disorders, and panic attacks) and drug use during the previous 12 months. Sociodemographic and clinical factors associated with screening positive for any psychiatric disorder and drug dependence were examined in multivariate logistic regression analyses.
RESULTS: Nearly half of the sample screened positive for a psychiatric disorder, nearly 40% reported using an illicit drug other than marijuana, and more than 12% screened positive for drug dependence during the previous 12 months. Factors independently associated with screening positive for a psychiatric disorder included number of HIV-related symptoms, illicit drug use, drug dependence, heavy alcohol use, and being unemployed or disabled. Factors independently associated with screening positive for drug dependence included having many HIV-related symptoms, being younger, being heterosexual, having frequent heavy alcohol use, and screening positive for a psychiatric disorder.
CONCLUSIONS: Many people infected with HIV may also have psychiatric and/or drug dependence disorders. Clinicians may need to actively identify those at risk and work with policymakers to ensure the availability of appropriate care for these treatable disorders.

Entities:  

Mesh:

Year:  2001        PMID: 11483137     DOI: 10.1001/archpsyc.58.8.721

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  522 in total

1.  Psychological aspects of living with HIV disease: a primary care perspective.

Authors:  R H Remien; J G Rabkin
Journal:  West J Med       Date:  2001-11

2.  Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders.

Authors:  R A Nolan; R Muir; K Runner; E K Haddad; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2018-12-05       Impact factor: 4.147

3.  Sex differences in pain and misuse of prescription analgesics among persons with HIV.

Authors:  Jennie C I Tsao; Judith A Stein; Aram Dobalian
Journal:  Pain Med       Date:  2010-04-29       Impact factor: 3.750

4.  Benefits of adherence to psychotropic medications on depressive symptoms and antiretroviral medication adherence among men and women living with HIV/AIDS.

Authors:  Dean G Cruess; Seth C Kalichman; Christine Amaral; Connie Swetzes; Chauncey Cherry; Moira O Kalichman
Journal:  Ann Behav Med       Date:  2012-04

5.  Use of alternative therapists among people in care for HIV in the United States.

Authors:  Andrew S London; Carrie E Foote-Ardah; John A Fleishman; Martin F Shapiro
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

6.  Drinking motives as prospective predictors of outcome in an intervention trial with heavily drinking HIV patients.

Authors:  Jennifer C Elliott; Efrat Aharonovich; Ann O'Leary; Milton Wainberg; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2013-11-05       Impact factor: 4.492

7.  Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV.

Authors:  William C Becker; Kirsha Gordon; E Jennifer Edelman; Robert D Kerns; Stephen Crystal; James D Dziura; Lynn E Fiellin; Adam J Gordon; Joseph L Goulet; Amy C Justice; David A Fiellin
Journal:  AIDS Behav       Date:  2016-03

8.  Current electroconvulsive therapy practice and research in the geriatric population.

Authors:  Nancy Kerner; Joan Prudic
Journal:  Neuropsychiatry (London)       Date:  2014-02

9.  A Novel Integrated Cognitive-Behavioral Therapy for Anxiety and Medication Adherence Among Persons Living With HIV/AIDS.

Authors:  Charles P Brandt; Daniel J Paulus; Monica Garza; Chad Lemaire; Peter J Norton; Michael J Zvolensky
Journal:  Cogn Behav Pract       Date:  2017-03-02

10.  The mental health impact of AIDS-related mortality in South Africa: a national study.

Authors:  L Myer; S Seedat; D J Stein; H Moomal; D R Williams
Journal:  J Epidemiol Community Health       Date:  2008-12-15       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.